A genetic signature can predict prognosis and response to therapy in breast cancer: Oncotype DX. (Q40264399)

19 September 2017

A genetic signature can predict prognosis and response to therapy in breast cancer: Oncotype DX. (English)

1 reference

19 September 2017

Virginia Kaklamani

1

1 reference

PubMed ID

17140367

19 September 2017

language of work or name

1 reference

1 November 2006

1 reference

Expert Review of Molecular Diagnostics: new diagnostic technologies are set to revolutionise healthcare

19 September 2017

1 reference

19 September 2017

6

1 reference

19 September 2017

6

1 reference

19 September 2017

803-809

1 reference

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

19 September 2017

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.6.803

National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1-3, 2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.6.803

Molecular portraits of human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.6.803

Measurement of gene expression in archival paraffin-embedded tissues: development and performance of a 92-gene reverse transcriptase-polymerase chain reaction assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.6.803

A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.6.803

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.6.803

A population-based study of tumor gene expression and risk of breast cancer death among lymph node-negative patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.6.803

Prognostic role of a multigene reverse transcriptase-PCR assay in patients with node-negative breast cancer not receiving adjuvant systemic therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.6.803

Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.6.803

Gene expression profiles in paraffin-embedded core biopsy tissue predict response to chemotherapy in women with locally advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.6.803

Markov models in medical decision making: a practical guide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.6.803

Gene expression profiling predicts clinical outcome of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.6.803

Multicenter validation of a gene expression-based prognostic signature in lymph node-negative primary breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.6.803

Concordance among gene-expression-based predictors for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.6.803

Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.6.803

A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.6.803

21 January 2018

Identifiers

DOI

10.1586/14737159.6.6.803

1 reference

19 September 2017

1 reference

PubMed ID

17140367